nucleotide binding oligomerization domain containing 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| cellular response to lipopolysaccharide | ||
| cellular response to peptidoglycan | ||
| cellular response to muramyl dipeptide | ||
| cellular response to muramyl dipeptide | ||
| cellular response to organic cyclic compound |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| actin binding | ||
| protein binding | ||
| ATP binding | ||
| enzyme binding | ||
| protein kinase binding |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0050678 | Blau syndrome | |
| DOID:0050861 | colorectal adenocarcinoma | |
| DOID:0050922 | gastrointestinal carcinoma | |
| DOID:0080176 | meningococcal meningitis | |
| DOID:0081267 | graft-versus-host disease | |
| DOID:0081451 | PFAPA syndrome | |
| DOID:1024 | leprosy | |
| DOID:1324 | lung cancer | |
| DOID:13241 | Behcet's disease | |
| DOID:13406 | pulmonary sarcoidosis |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026